These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 37750041)
1. Longitudinal dysregulation of long non-coding RNAs in Parkinson's disease. Müller-Nedebock AC; Cuttler K; Pfaff AL; Kõks S Exp Biol Med (Maywood); 2023 Oct; 248(20):1780-1784. PubMed ID: 37750041 [TBL] [Abstract][Full Text] [Related]
2. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report. Kraus TFJ; Haider M; Spanner J; Steinmaurer M; Dietinger V; Kretzschmar HA Mol Neurobiol; 2017 May; 54(4):2869-2877. PubMed ID: 27021022 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease. Rezaei O; Nateghinia S; Estiar MA; Taheri M; Ghafouri-Fard S Eur J Pharmacol; 2021 Apr; 896():173914. PubMed ID: 33508286 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing. Soreq L; Guffanti A; Salomonis N; Simchovitz A; Israel Z; Bergman H; Soreq H PLoS Comput Biol; 2014 Mar; 10(3):e1003517. PubMed ID: 24651478 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement. Garofalo M; Pandini C; Bordoni M; Pansarasa O; Rey F; Costa A; Minafra B; Diamanti L; Zucca S; Carelli S; Cereda C; Gagliardi S Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327559 [TBL] [Abstract][Full Text] [Related]
6. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease. Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187 [TBL] [Abstract][Full Text] [Related]
7. A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra. Simchovitz A; Hanan M; Yayon N; Lee S; Bennett ER; Greenberg DS; Kadener S; Soreq H Aging Cell; 2020 Mar; 19(3):e13115. PubMed ID: 32080970 [TBL] [Abstract][Full Text] [Related]
8. Long Non-coding RNAs in Parkinson's Disease. Xin C; Liu J Neurochem Res; 2021 May; 46(5):1031-1042. PubMed ID: 33544326 [TBL] [Abstract][Full Text] [Related]
9. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease. Salemi M; Lanza G; Mogavero MP; Cosentino FII; Borgione E; Iorio R; Ventola GM; Marchese G; Salluzzo MG; Ravo M; Ferri R Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163455 [TBL] [Abstract][Full Text] [Related]
10. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease. Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease. Huang T; Zhao JY; Pan RR; Jiang T; Fu XX; Huang Q; Wang XX; Gong PY; Tian YY; Zhang YD Mol Neurobiol; 2023 Jan; 60(1):317-328. PubMed ID: 36264433 [TBL] [Abstract][Full Text] [Related]
12. Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease. Li J; Sun Y; Chen J Genes Genet Syst; 2019 Apr; 94(2):61-69. PubMed ID: 30713215 [TBL] [Abstract][Full Text] [Related]
13. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases. Sivagurunathan N; Ambatt ATS; Calivarathan L Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899 [TBL] [Abstract][Full Text] [Related]
14. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease. Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570 [TBL] [Abstract][Full Text] [Related]
15. Significant Role of Long Non-coding RNAs in Parkinson's Disease. Na C; Wen-Wen C; Li W; Ao-Jia Z; Ting W Curr Pharm Des; 2022; 28(37):3085-3094. PubMed ID: 36154598 [TBL] [Abstract][Full Text] [Related]
16. Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinson's Disease. Khish NS; Ghiasizadeh P; Rasti A; Moghimi O; Zadeh AZ; Bahiraee A; Ebrahimi R Curr Med Chem; 2024; 31(34):5576-5597. PubMed ID: 37592769 [TBL] [Abstract][Full Text] [Related]
17. The landscape of programmed cell death-related lncRNAs in Alzheimer's disease and Parkinson's disease. Zhao N; Wang J; Huang S; Zhang J; Bao J; Ni H; Gao X; Zhang C Apoptosis; 2024 Oct; 29(9-10):1584-1599. PubMed ID: 38853201 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes. Bao J; Chang W; Zhao Y J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466 [TBL] [Abstract][Full Text] [Related]
19. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer. Li F; Huang C; Li Q; Wu X Med Sci Monit; 2018 Jan; 24():37-49. PubMed ID: 29295970 [TBL] [Abstract][Full Text] [Related]
20. Genome-Scale Expression Pattern of Long Non-Coding RNAs in Chinese Uyghur Patients with Parkinson's Disease. Wang D; Gao H; Li Y; Jiang S; Yong Y; Yang X Med Sci Monit; 2020 Oct; 26():e925888. PubMed ID: 33031356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]